Atlas Trials

A Randomized Controlled Study of Serplulimab Combined With Chemotherapy for Locally Advanced Gastric Adenocarcinoma

Clinical trial NCT07257575 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07257575
Sponsor
Guangdong Provincial People's Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer Stage III
Start date
2025-01-05
Primary completion
2027-01-31
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.